Viewing Study NCT04545632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2026-01-24 @ 11:10 PM
Study NCT ID: NCT04545632
Status: COMPLETED
Last Update Posted: 2022-07-27
First Post: 2020-07-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor
Sponsor: Boryung Pharmaceutical Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None NSCLC View
None Prostate Cancer View
None Head and Neck Cancer View
None Gastric Cancer View
None Esophageal Cancer View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chemotherapy View
None Ethanol-containing docetaxel View